PUF Ventures Inc. (CSE: PUF, Frankfurt: PU3, OTCPK: PUFXF), an advanced Access to Cannabis for Medical Purposes Regulations (“ACMPR”) license applicant, is pleased to announce Health Canada has contacted AAA Heidelberg to acknowledge the company’s position in the ACMPR licensing process which is the confirmation of readiness stage. Upon receipt and successful review of an evidence package, AAA Heidelberg can expect to receive an ACMPR license to grow medical cannabis.
“We have worked closely with Health Canada throughout the process and we are pleased to receive favourable acknowledgement from Health Canada with respect to our ACMPR license application,” said Derek Ivany, President and CEO of PUF Ventures Inc. “We have already initiated the process of preparing this extensive evidence package for the confirmation of readiness; it includes documentation, detailed video, supporting photos, and we must clearly demonstrate the ability to meet the Health Canada requirements for storage of product, security and access control, record keeping and quality control. We are confident our evidence will meet and exceed the requirements and look forward to a quick review of our forthcoming submission.”
With the recent success of Solaris Nutraceutical’s 1.2 million sq. ft. greenhouse project in Australia of identifying the location, creating greenhouse design concepts and filing permits and applications with local authorities, PUF is looking to replicate the project plan in other cannabis friendly jurisdictions around the world.
“I am extremely pleased with the progress we are making in Canada and Australia and recognize that there are other opportunities in additional international markets,” continued Mr. Ivany. “We will be investigating other locations and opportunities as we continue our quest to create shareholder value and become a leading international cannabis producer.”
About PUF Ventures Inc.
PUF Ventures Inc. is a growth oriented and diversified company focused on the international cannabis industry. It has ownership in several cannabis companies: AAA Heidelberg, Solaris Nutraceuticals Pty Ltd., and Natures Hemp Corp., and is actively pursuing other opportunities within the industry. PUF has an option to purchase 100% of AAA Heidelberg Inc., a private Ontario company and advanced applicant for an ACMPR license. Solaris Nutraceuticals is building the largest medical cannabis greenhouse in the Southern Hemisphere. For more information please visit: www.puf.ca.
ON BEHALF OF THE BOARD OF DIRECTORS
President & CEO
No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.
Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer’s future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.
SOURCE PUF Ventures